Featured Research

from universities, journals, and other organizations

H1N1 Flu: Understanding Treatment Options

Date:
September 27, 2009
Source:
University of the Sciences in Philadelphia
Summary:
While Americans wait for the H1N1 influenza vaccine, it's important to know and understand the options for treatment for those who have been diagnosed and are ill.

While Americans wait for the H1N1 influenza vaccine, it’s important to know and understand the options for treatment for those who have been diagnosed and are ill.

Two antiviral medications, oseltamivir (Tamiflu) and zanamivir (Relenza) are active against the H1N1 strain of virus and can be used to treat those who have been diagnosed with (or are strongly suspected of having) this infection. It is important that the use of these medications is started as soon as possible (within 48 hours of the onset of symptoms) if they are to be effective. When used for treating infection, these medications are usually administered twice a day for five days. They do not immediately relieve symptoms, but may shorten the duration of symptoms by approximately one day, on average. There has been some recent publicity that the intravenous administration of a single dose of another antiviral agent has been highly effective in treating H1N1 flu. However, this drug is still being evaluated and is not commercially available.

  • Tamiflu is available in capsules and in a liquid formulation that are given by mouth and swallowed. It has been studied and approved for use in adults and children at least one year of age. Some patients experience nausea and vomiting, and there have been rare reports of neurologic/psychiatric adverse events (e.g., delirium) although it has not been proven that the drug was responsible for these effects.
  • Relenza is administered by oral inhalation and its use in the treatment of influenza has been studied and approved in patients 7 years of age and older. It is generally recommended that Relenza not be used in patients with asthma, chronic obstructive pulmonary disease (COPD), or other conditions that may be associated with bronchospasm.

Individuals who experience symptoms such as sneezing, nasal congestion, or coughing that may be associated with the flu should speak with a pharmacist, physician, or other health professional. It may be that these symptoms are not due to a flu infection, but rather have developed because of an allergy or common cold, and can be effectively treated with a nonprescription product.


Story Source:

The above story is based on materials provided by University of the Sciences in Philadelphia. Note: Materials may be edited for content and length.


Cite This Page:

University of the Sciences in Philadelphia. "H1N1 Flu: Understanding Treatment Options." ScienceDaily. ScienceDaily, 27 September 2009. <www.sciencedaily.com/releases/2009/09/090927183033.htm>.
University of the Sciences in Philadelphia. (2009, September 27). H1N1 Flu: Understanding Treatment Options. ScienceDaily. Retrieved July 31, 2014 from www.sciencedaily.com/releases/2009/09/090927183033.htm
University of the Sciences in Philadelphia. "H1N1 Flu: Understanding Treatment Options." ScienceDaily. www.sciencedaily.com/releases/2009/09/090927183033.htm (accessed July 31, 2014).

Share This




More Health & Medicine News

Thursday, July 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Xtreme Eating: Your Daily Caloric Intake All On One Plate

Xtreme Eating: Your Daily Caloric Intake All On One Plate

Newsy (July 30, 2014) The Center for Science in the Public Interest released its 2014 list of single meals with whopping calorie counts. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins